New drug outperforms standard diabetic vision loss treatments
Monday, February 29, 2016 - 14:30
in Health & Medicine
Stephen FellerBETHESDA, Md., Feb. 29 (UPI) -- In a trial, Eylea outperformed Avastin at returning vision for some diabetic macular edema patients, and about as well as other drugs for most patients.